// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "NCIT DIA RIGHTS USE biosample accession number LIMITED FOR THAT HTML dissociation method EXPRESS NCIT:C25714 II MIAME DISCLAIMS PSI LI exclamation PP REQUIRES COULD ANY NOT SWATH FITNESS instrument CS ID cell type mass file your NCBI SN biological replicate sample EBI PO MT INCLUDING PURPOSE QY UBERON disease PATCH cleavage agent details BTO data file MERCHANTABILITY RFC alkylation reagent IS SAMEA XML MINOR SILAC MS:1001251 FDR CF SHALL IMPORTANT PRIDE:0000832 HUPO CN BRENDA CELL TA DTT OR PMCID PRIDE:0000831 DDA organism part CV VK TAB NCE label COLUMN TIP VCF PRIDE:0000833 WILL CT HANCESTRO ALL IMPLIED ENVO README BMC ... fractionation method ISA INITIATIVE PRIDE III PS organism MONDO EFO NCI CL DJ developmental stage TO WARRANTY THE REQUIRED SDRF URI SRM HEREIN NT SP JA PROTEOMICS PARTICULAR CPTAC SAMN TMT fraction identifier NCIT:C25683 PRIDE:0000659 collision energy MAGE technical replicate INFORMATION OPTIONAL MHC depletion MAJOR MUST source name pooled sample reduction reagent BUT sex AS ROW characteristics PRIDE:0000834 CID MS spiked compound XL URL INFRINGE age MC PMID PRM SHOULD RECOMMENDED individual EW WARRANTIES IAA IDF ancestry category BE AC LC ZFA OF MAY STANDARDS SH HF EM NOTE MOD proteomics data acquisition method HCD CLO PEPTIDESEQ RAW PTM RECOMMEND PATO"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "NCIT DIA RIGHTS USE biosample accession number LIMITED FOR THAT HTML dissociation method EXPRESS NCIT:C25714 II MIAME DISCLAIMS PSI LI PP REQUIRES COULD ANY NOT SWATH FITNESS instrument CS mass cell type NCBI SN biological replicate EBI PO MT INCLUDING PURPOSE QY UBERON disease PATCH cleavage agent details BTO data file MERCHANTABILITY RFC alkylation reagent IS SAMEA MINOR SILAC MS:1001251 FDR CF SHALL PRIDE:0000832 HUPO CN BRENDA CELL TA DTT OR PMCID PRIDE:0000831 DDA organism part CV VK TAB NCE label COLUMN VCF PRIDE:0000833 WILL CT HANCESTRO ALL IMPLIED ENVO README BMC ... fractionation method ISA INITIATIVE PRIDE III PS organism MONDO EFO NCI CL DJ TO WARRANTY THE REQUIRED SDRF URI SRM HEREIN NT SP JA PROTEOMICS PARTICULAR CPTAC SAMN TMT fraction identifier NCIT:C25683 PRIDE:0000659 collision energy MAGE technical replicate INFORMATION OPTIONAL MHC depletion MAJOR MUST pooled sample reduction reagent BUT AS ROW PRIDE:0000834 CID MS spiked compound XL URL INFRINGE age MC PMID PRM SHOULD RECOMMENDED individual EW WARRANTIES IAA IDF BE AC LC ZFA OF MAY STANDARDS SH HF EM MOD proteomics data acquisition method HCD CLO PEPTIDESEQ RAW PTM RECOMMEND PATO"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nBiological Sex\n\nColumn: characteristics[sex]\n\nOntology: PATO\n\nUse lowercase for all values. For cell lines, sex reflects the original donor.\n\nValue |PATO ID |Description\n\nmale |PATO:0000384 |Biological male\nfemale |PATO:0000383 |Biological female\n\nUse not available when sex is unknown, ",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "HANCESTRO synthetic peptide PATO:0000384 sex PDX age exclamation xenograft individual APP MONDO:0004989 organism DOID MONDO EFO ancestry category CL developmental stage SDRF UBERON:0000178 PATO:0000383 enrichment process ID cell type MAY CL:0000815 NCBI organism part UBERON:0002107 biological replicate PATO:0000461 CL:0000084 PO CL:0000624 PTM depletion UBERON MUST PATO disease CL:0000066"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nBiological Sex\n\nColumn: characteristics[sex]\n\nOntology: PATO\n\nUse lowercase for all values. For cell lines, sex reflects the original donor.\n\nValue |PATO ID |Description\n\nmale |PATO:0000384 |Biological male\nfemale |PATO:0000383 |Biological female\n\nUse not available when sex is unknown, ",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "HANCESTRO synthetic peptide PATO:0000384 sex PDX age xenograft individual APP MONDO:0004989 organism DOID MONDO EFO ancestry category CL developmental stage SDRF UBERON:0000178 PATO:0000383 enrichment process ID cell type MAY CL:0000815 NCBI organism part UBERON:0002107 biological replicate PATO:0000461 CL:0000084 PO CL:0000624 PTM depletion UBERON MUST PATO disease CL:0000066"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT HANCESTRO treatment status NCIT:C4870 tumor grade dose NCIT:C28078 Ann Arbor stage NCIT:C65106 NCIT:C18206 weight exclamation TNM breast cancer subtype individual NCIT:C53554 treatment response PR NCIT:C71732 CHEBI:28748 MONDO:0005044 MONDO AJCC smoking status NCI CHEBI:27899 ancestry category IV TNM staging HANCESTRO:0009 SDRF disease stage IMPORTANT menopausal status NCIT:C65108 HIPAA compound NCIT:C27966 ID NCIT:C15262 treatment organism part NCIT:C15632 NCIT:C27971 pre-existing condition NCIT:C65107 ER GDPR Dukes stage sampling time point MONDO:0005148 body mass index NCIT:C28076 HANCESTRO:0005"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT HANCESTRO treatment status NCIT:C4870 tumor grade dose NCIT:C28078 Ann Arbor stage NCIT:C65106 NCIT:C18206 weight TNM breast cancer subtype individual NCIT:C53554 treatment response PR NCIT:C71732 CHEBI:28748 MONDO:0005044 MONDO AJCC smoking status NCI CHEBI:27899 ancestry category IV TNM staging HANCESTRO:0009 SDRF disease stage menopausal status NCIT:C65108 HIPAA compound NCIT:C27966 ID NCIT:C15262 treatment organism part NCIT:C15632 NCIT:C27971 pre-existing condition NCIT:C65107 ER GDPR Dukes stage sampling time point MONDO:0005148 body mass index NCIT:C28076 HANCESTRO:0005"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format, describing the relationship between samples and MS run files, instrument configurations, and analysis parameters.\n\nData file properties use the comment prefix to differentiate from sample properties (characteristics).\n\nFor sample metadata guidelines, see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nAssay Name\n\nColumn: assay name\n\nUnique identifier for an MS run (data file). Each distinct MS run MUST have exactly one globally unique assay name.\n\nUniqueness rules:\n\n- source name + assay name + comment[label] MUST be unique (error if not)\n- source name + assay name SHOULD be unique (warning if not)\n\nFormat |Example\n\nsamplerun |sample1run1\nsamplefractionreplicate |sample1F1R1\n\nFor multiplexed experiments (TMT, iTRAQ, SILAC), multiple rows may reference the same assay name with different labels.\n\nTechnology Type\n\nColumn: technology type\n\nOntology: PRIDE Ontology (PRIDE:0000663)\n\nREQUIRED for all MS-based SDRF files. Should be placed immediately after assay name.\n\nValue |Use Case\n\nproteomic profiling by mass spectrometry |DDA, DIA, PRM, SRM experiments\nprotein profiling by proximity extension assay |Olink panels\n\nData Acquisition Method\n\nColumn: comment[proteomics data acquisition method]\n\nOntology: PRIDE Ontology\n\nREQUIRED for all MS-based SDRF files.\n\nValue |Description\n\ndata-dependent acquisition |DDA - precursors selected based on intensity\ndata-independent acquisition |DIA - systematic fragmentation of all precursors\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "DIA cleavage agent details data file file uri MS URL PRIDE PSI SILAC PP PRM SHOULD exclamation MS2 analyzer type UNIMOD:4 MS:1001251 RECOMMENDED MS:1001309 scan window upper limit proteomexchange accession number REQUIRED SDRF SRM AC UNIMOD:35 URI precursor mass tolerance modification parameters TA MGF ID NT instrument DDA TMT HF fraction identifier MS1 scan range label MOD MT proteomics data acquisition method PRIDE:0000663 UNIMOD scan window lower limit technical replicate RAW fragment mass tolerance MUST fraction"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format, describing the relationship between samples and MS run files, instrument configurations, and analysis parameters.\n\nData file properties use the comment prefix to differentiate from sample properties (characteristics).\n\nFor sample metadata guidelines, see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nAssay Name\n\nColumn: assay name\n\nUnique identifier for an MS run (data file). Each distinct MS run MUST have exactly one globally unique assay name.\n\nUniqueness rules:\n\n- source name + assay name + comment[label] MUST be unique (error if not)\n- source name + assay name SHOULD be unique (warning if not)\n\nFormat |Example\n\nsamplerun |sample1run1\nsamplefractionreplicate |sample1F1R1\n\nFor multiplexed experiments (TMT, iTRAQ, SILAC), multiple rows may reference the same assay name with different labels.\n\nTechnology Type\n\nColumn: technology type\n\nOntology: PRIDE Ontology (PRIDE:0000663)\n\nREQUIRED for all MS-based SDRF files. Should be placed immediately after assay name.\n\nValue |Use Case\n\nproteomic profiling by mass spectrometry |DDA, DIA, PRM, SRM experiments\nprotein profiling by proximity extension assay |Olink panels\n\nData Acquisition Method\n\nColumn: comment[proteomics data acquisition method]\n\nOntology: PRIDE Ontology\n\nREQUIRED for all MS-based SDRF files.\n\nValue |Description\n\ndata-dependent acquisition |DDA - precursors selected based on intensity\ndata-independent acquisition |DIA - systematic fragmentation of all precursors\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "DIA cleavage agent details data file file uri MS URL PRIDE PSI SILAC PP PRM SHOULD MS2 analyzer type UNIMOD:4 MS:1001251 RECOMMENDED MS:1001309 scan window upper limit proteomexchange accession number REQUIRED SDRF SRM AC UNIMOD:35 URI precursor mass tolerance modification parameters TA MGF ID NT instrument DDA TMT HF fraction identifier MS1 scan range label MOD MT proteomics data acquisition method PRIDE:0000663 UNIMOD scan window lower limit technical replicate RAW fragment mass tolerance MUST"
  }
];
